Tagworks will present on the preclinical development of the first-in-class click-cleavable ADC TGW101, targeting non-internalizing pan-carcinoma marker TAG72; as well as TGW211, a first-in-class HER2-directed radioimmunoconjugate.  This presentation is part of the Engineering ADC Conjugates session on November 12, 2025, starting at 11.45 in Lisbon, Portugal. https://www.pegsummiteurope.com

Tagworks will present the IND-enabling data of the first in class click-cleavable ADC, TGW101, targeting non-internalizing pan-carcinoma marker TAG72

Marc Robillard will present the progress of Tagworks click-cleavable radiotherapeutics program at the 6th Targeted Radiopharmaceuticals Summit in Amsterdam on December 5, 2024.

Madeira, September 4-6, 2024; www.antibodyseries.com

Boston, September 9-10, 2024; www.adc-partnering.com

Boston, August 20-22, 2024; www.adc-linker-conjugation.com

We are pleased to announce the appointment of Bianca Matthee as our VP of Research Operations.

Marc Robillard will present Tagworks at the 24th BioEquity Europe on May 14 at 11:30 in San Sebastián, Spain.

We are pleased to announce the recent appointments of Maria V. Cincotta as our VP of Clinical Operations & Program Management and Tu-Anh T. Bui as our VP of CMC & Technical Operations.

The 17th Annual European Life Sciences CEO Forum will take place on the 28th - 29th February 2024 back at the Hilton Zurich Airport Hotel. The event will be part of the Sachs Spring Life Sciences Week.